The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
about
Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials5-alpha-reductase inhibitors for prostate cancer preventionFinasteride for benign prostatic hyperplasia5alpha-reductase: history and clinical importanceTissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expressionCurrent medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitationsThe effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young menFinasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials.The effectiveness of reducing the daily dose of finasteride in men with benign prostatic hyperplasiaTherapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate CancerAndrogens and prostate diseaseAdverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic ReviewEvidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasiaEffect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled studyCodon 89 polymorphism in the human 5 alpha-reductase gene in primary breast cancerAnaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancerEfficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year StudyFinasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialClinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia.A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats.Magnetic resonance imaging and morphometric histologic analysis of prostate tissue composition in predicting the clinical outcome of terazosin therapy in benign prostatic hyperplasia.Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy.Finasteride-induced thrombocytopenia.Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based samplePharmacotherapy for benign prostatic hyperplasia.The effect of 5α-reductase-2 deficiency on human fertilityVariability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.Treatment of prostate cancer.Qianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF-1α signaling pathway.Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options.Clinical application of 5alpha-reductase inhibitors.Clinical pearls in men's health.Management of urinary incontinence.Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues.Subtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia.Hormonal treatment for prostate cancer.Dutasteride for the treatment of prostate-related conditions.Role of 5α-reductase inhibitors in benign prostatic diseases.Effect of turosteride, a 5 alpha-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma.Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture.
P2860
Q21245273-C1C55104-31A1-4602-A9C6-64F1D63C44D1Q22252970-945C344A-57BB-4507-BA4E-D026209A17B4Q24234464-362A9B45-9383-4F9C-80C0-DF221E60D63CQ24546176-67B912A2-6C9E-4E33-856D-B57A7B016111Q24596101-B55098BD-1D58-46EA-9C9A-573980E17A6DQ24649617-80BF4790-19BE-4687-9C7E-B1BDAAFA3419Q24658075-FFC40A56-AA98-4722-94DC-57D10278EC82Q24795452-B4B28FCE-F757-4403-8EBF-AEC1D75E2ADEQ24800317-5358775D-062E-4A91-867F-044C36E89680Q26750620-6AAC3377-D217-41E1-AF3C-CAC1FEF5BEA4Q27010093-20A17DE9-3EEB-4106-8AF8-A5E14FA3621BQ28069186-014A5995-F22E-4F69-B04A-B55EFDE36867Q28077954-BE999FD5-3827-4AAA-8BC9-2F4C57DE4C3DQ28182845-383AF7FC-C92D-4327-A2ED-18EB1FCFEF5AQ28360883-50A313DA-7CFA-4238-BEC5-5ED236C3E5E0Q28375064-381D4FC5-5B5B-4600-8D85-761EBBDB1C3AQ28379286-54503799-C89F-4B2E-86C5-1830C8A57E87Q28547130-5040C851-D356-4F34-9842-26AF8298078EQ30408224-E0A5FA22-58D0-4995-B226-98E9A6CB56CBQ32133215-E3F7F81B-906B-42B9-9E9B-9C0A1FB1DAF6Q32155122-1199D900-A8E3-4B18-A6D7-008506673189Q33156578-73C70DD0-6296-4EF5-8B59-673891F8D398Q33343320-51FE262C-F90D-4D3E-9237-06B60485F01EQ33578216-C49242E6-DFFA-4776-BB64-13662B91C4DEQ33608293-0DDCED05-2F88-4B1A-B60B-83A373C796B0Q33653004-BE013D17-335E-47ED-8FE6-0CB623527F35Q33658285-0BC51531-1B82-42A1-BF4D-378F6269BA26Q33668839-5CAC1C98-EF8C-4CC5-9060-574F932D9CDFQ33769561-EE7C8780-EAA5-4CC4-A3BB-EBEC71C15138Q33797223-B84B7BA7-4C51-4A36-9004-A6E7310F48C1Q33943526-B9EE7CA8-7E9F-479D-BE8A-5F0ACC827205Q33951568-E6D08CED-5C49-49CE-85A6-82454EC41A30Q34022658-8E6956D8-CB99-4318-AA64-94C84131A274Q34064040-D07223EF-BA2F-410A-95AC-B306009E721CQ34119559-CC59384B-8D13-4B43-82E2-D87A4E0ABC37Q34167174-01DB1C8D-4860-4D6C-9AF7-D42626A9E06CQ34252953-D990AE62-5049-48AF-875A-E61EFC2C4346Q34254296-F63F4B4A-755B-4D32-8553-E36EB54C1530Q34418086-CB0F13F3-17ED-4933-AE53-1888AC765EFFQ34435182-63D25DBD-60F9-4B24-B1BF-90A585BD15E7
P2860
The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The effect of finasteride in m ...... . The Finasteride Study Group.
@ast
The effect of finasteride in m ...... . The Finasteride Study Group.
@en
type
label
The effect of finasteride in m ...... . The Finasteride Study Group.
@ast
The effect of finasteride in m ...... . The Finasteride Study Group.
@en
prefLabel
The effect of finasteride in m ...... . The Finasteride Study Group.
@ast
The effect of finasteride in m ...... . The Finasteride Study Group.
@en
P2093
P1476
The effect of finasteride in m ...... . The Finasteride Study Group.
@en
P2093
Andriole GL
Bracken BR
Bruskewitz RC
Gormley GJ
Imperato-McGinley J
McConnell JD
Tenover JS
P304
P356
10.1056/NEJM199210223271701
P407
P577
1992-10-01T00:00:00Z